POLAREAN IMAGING PLC
Develops and commercializes hyperpolarized gas MRI solutions for pulmonary imaging.
POLX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BF3DT583
- LEI:
- 213800DGR2BHXJ36OL37
- Country:
- United States of America
- Address:
- 2500 MERIDIAN PARKWAY, 27713 DURHAM
- Website:
- https://polarean.com
- Sector:
- Manufacturing
Description
Polarean Imaging PLC is a medical technology company that develops and commercializes solutions for pulmonary imaging. The company's core focus is its drug-device combination product utilizing hyperpolarized Xenon-129 gas Magnetic Resonance Imaging (XeMRI). This non-invasive, radiation-free technique provides a direct, functional assessment of lung ventilation in a single breath-hold. Polarean developed XENOVIEW™ (xenon Xe 129 hyperpolarized), the first and only hyperpolarized MRI contrast agent approved by the U.S. FDA for evaluating lung ventilation. The technology platform includes the HPX Hyperpolarizer system, specialized gas blends, and dedicated MRI coils, designed to aid in the diagnosis and management of chronic lung diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-01 08:35 |
Chest coil passes Philips compatibility testing
|
English | 21.1 KB | ||
| 2025-11-25 08:25 |
First Xenon Hyperpolariser in Asia
|
English | 20.4 KB | ||
| 2025-11-24 08:10 |
Korean distributor agreement with DK Healthcare
|
English | 19.4 KB | ||
| 2025-11-14 08:20 |
Proposed Cancellation of Admission & Notice of GM
|
English | 91.5 KB | ||
| 2025-10-22 08:00 |
Strategic review and consideration of AIM listing
|
English | 16.9 KB | ||
| 2025-09-29 08:00 |
University of Virginia Health Hospital agreement
|
English | 21.9 KB | ||
| 2025-09-16 08:00 |
Notice of Results
|
English | 14.3 KB | ||
| 2025-09-11 17:36 |
Holding(s) in Company
|
English | 23.1 KB | ||
| 2025-08-12 08:00 |
Submission of new Phase III study protocol to FDA
|
English | 20.5 KB | ||
| 2025-07-24 08:00 |
Block Listing Six Monthly Return
|
English | 22.2 KB | ||
| 2025-06-24 08:00 |
Promotion & sales representative agreement
|
English | 20.2 KB | ||
| 2025-06-02 08:00 |
FDA expands XENOVIEW indication
|
English | 21.0 KB | ||
| 2025-05-15 13:48 |
Xenon MRI featured prominently at ATS 2025
|
English | 51.6 KB | ||
| 2025-05-14 15:25 |
Ongoing collaboration with Philips
|
English | 13.0 KB | ||
| 2025-03-10 08:00 |
Expansion of Xenon MRI imaging platform
|
English | 22.6 KB |
Automate Your Workflow. Get a real-time feed of all POLAREAN IMAGING PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for POLAREAN IMAGING PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for POLAREAN IMAGING PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
